This NDC is on FDA's drug shortage list (posted Dec 3, 2021)
Product Information
BACTERIOSTATIC WATER VIAL is a generic product labeled by Hospira Inc., priced at $0.1924 per ML under NDC 00409397703. Its NADAC has been published 315 times since Nov 28, 2013.
FDA first approved this application on Oct 27, 1982. Its Orange Book therapeutic-equivalence code is AP.
Strength
1 mL/mL
Manufacturer
Hospira Inc.NDC
00409397703
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
WATERApproval Type
New Drug (NDA)
FDA Application
NDA018802FDA Approved
10/27/1982
TE Code
AP
On Market Since
4/30/2005
Price Statistics
The NADAC for BACTERIOSTATIC WATER VIAL has been published 315 times since Nov 28, 2013, and over the history we have for it it has risen 646.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1924 per ML |
|---|---|
| All-time high | $0.1924 (Sep 30, 2026) |
| All-time low | $0.0258 (Nov 28, 2013) |
| 52-week high | $0.1924 |
| 52-week low | $0.0785 |
| Median price | $0.0328 |
| Average price | $0.0553 |
| Largest weekly change | +67.3% (Apr 17, 2024) |
| Weeks tracked | 315 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Bacteriostatic Water market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hospira Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Bacteriostatic Water market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BACTERIOSTATIC WATER VIAL?
The current National Average Drug Acquisition Cost (NADAC) for BACTERIOSTATIC WATER VIAL, manufactured by Hospira Inc., is $0.1924 per ML (NDC 00409397703), effective Sep 30, 2026.
How has the price of BACTERIOSTATIC WATER VIAL changed over time?
Over the history we have for it, the NADAC for BACTERIOSTATIC WATER VIAL has risen 646.2%. It has been tracked across 315 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for BACTERIOSTATIC WATER VIAL?
Since Nov 28, 2013, the NADAC for BACTERIOSTATIC WATER VIAL has ranged from a low of $0.0258 (Nov 28, 2013) to a high of $0.1924 (Sep 30, 2026), with a median of $0.0328 per ML.
Are there cheaper alternatives to BACTERIOSTATIC WATER VIAL?
No other NADAC-published product currently shares the active ingredient and strength of BACTERIOSTATIC WATER VIAL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures BACTERIOSTATIC WATER VIAL?
BACTERIOSTATIC WATER VIAL (NDC 00409397703) is labeled by Hospira Inc., and CMS classifies it as a generic product.
Is BACTERIOSTATIC WATER VIAL in shortage?
Yes — NDC 00409397703 is currently listed in FDA's drug shortage database (posted Dec 3, 2021).